[1]栾学冰.拜阿斯匹林、那曲肝素联合氯吡格雷治疗急性ST段抬高型心肌梗死疗效[J].医学信息,2020,33(09):136-137.[doi:10.3969/j.issn.1006-1959.2020.09.043]
　LUAN Xue-bing.The Efficacy of Bayaspirin,Naltreparin Combined with Clopidogrel in the Treatment of Acute ST-segment Elevation Myocardial Infarction[J].Medical Information,2020,33(09):136-137.[doi:10.3969/j.issn.1006-1959.2020.09.043]
点击复制

拜阿斯匹林、那曲肝素联合氯吡格雷治疗急性ST段抬高型心肌梗死疗效()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年09期
页码:
136-137
栏目:
药物与临床
出版日期:
2020-05-01

文章信息/Info

Title:
The Efficacy of Bayaspirin,Naltreparin Combined with Clopidogrel in the Treatment of Acute ST-segment Elevation Myocardial Infarction
文章编号:
1006-1959（2020）09-0136-02
作者:
栾学冰
（佳木斯市中心医院心血管内科，黑龙江 佳木斯 154002）
Author(s):
LUAN Xue-bing
(Department of Cardiology,Jiamusi Central Hospital,Jiamusi 154002,Heilongjiang,China)
关键词:
拜阿斯匹林; 氯吡格雷; 那曲肝素; ST段抬高型心肌梗死
Keywords:
Bayaspirin; Clopidogrel; Naltreparin; ST-segment elevation myocardial infarction
分类号:
R542.2+2
DOI:
10.3969/j.issn.1006-1959.2020.09.043
文献标志码:
A
摘要:
目的 观察拜阿斯匹林、那曲肝素联合氯吡格雷治疗急性ST段抬高型心肌梗死临床效果。方法 选取2018年4月~2019年4月在我院诊治的102例急性ST段抬高型心肌梗死患者为研究对象，采用随机数字表法分为对照组和观察组，各51例。对照组采用拜阿斯匹林与那曲肝素联合治疗，观察组在对照组基础上加用氯吡格雷治疗，比较两组临床治疗总有效率、自发性ST段回落率、血管再通率及不良反应发生情况。结果 观察组治疗总有效率为94.11%，高于对照组的80.39%，差异有统计学意义（P＜0.05）；观察组自发性ST段回落率为92.15%，高于对照组的76.47%，差异有统计学意义（P＜0.05）；观察组血管再通率为72.54%，高于对照组的54.90%，差异有统计学意义（P＜0.05）；观察组不良反应发生率为3.91%，与对照组的1.96%比较，差异无统计学意义（P＞0.05）。结论 拜阿斯匹林、那曲肝素联合氯吡格雷三联治疗急性ST段抬高型心肌梗死疗效确切，有助于提高自发性ST段回落率和血管再通率，且临床不良反应少，联合用药安全可靠。
Abstract:
Objective To observe the clinical effect of bayaspirin,naltreparin combined with clopidogrel in the treatment of acute ST-segment elevation myocardial infarction.Methods A total of 102 patients with acute ST-segment elevation myocardial infarction diagnosed and treated in our hospital from April 2018 to April 2019 were selected as the research object. They were divided into a control group and an observation group with a random number table method, with 51 cases in each group.The control group was treated with bayaspirin and naltreparin, and the observation group was treated with clopidogrel on the basis of the control group. The total clinical treatment efficiency, spontaneous ST-segment fall rate, vascular recanalization rate, and adverse reactions were compared between the two groups.Results The total effective rate of treatment in the observation group was 94.11%, higher than 80.39% in the control group, the difference was statistically significant (P＜0.05); the spontaneous ST segment fallback rate in the observation group was 92.15%, higher than the control group’s 76.47%, the difference was statistically significant(P＜0.05);the vascular recanalization rate of the observation group was 72.54%, higher than that of the control group of 54.90%, the difference was statistically significant (P＜0.05); the incidence of adverse reactions in the observation group was 3.91%, and compared with 1.96% of the control group, the difference was not statistically significant (P＞0.05).Conclusion The combination of bayaspirin,naltreparin and clopidogrel in the treatment of acute ST-segment elevation myocardial infarction is definite, which is helpful to improve the spontaneous ST-segment fall rate and vascular recanalization rate,and there are few clinical adverse reactions, the combined medication is safe and reliable.

参考文献/References:

[1]田英姿.不同抗凝方式联合溶栓治疗急性ST段抬高型心肌梗死的护理[J].河南职工医学院学报,2014,26(2):174-176.[2]任学良,张吉廷.阿替普酶溶栓治疗ST段抬高型心肌梗死的临床评价[J].西南国防医药,2014,12(8):843-845.[3]封金伟,闫如海,王帅,等.急性心肌梗死溶栓再灌注后ST段反复演变伴恶性心律失常1例[J].心电与循环,2014,22(1):68-69.[4]刘云飞.替罗非班治疗急性ST段抬高型心肌梗死的疗效分析[J].中国实用医药,2014,6(36):54-55.[5]卢文娟,马丽娟,张正水.氯吡格雷联合阿司匹林治疗不稳定型心绞痛临床疗效观察[J].实用药物与临床,2014,13(24):159-160.[6]赵新华.氯吡格雷与拜阿司匹林和低分子肝素钙治疗非ST段抬高型心肌梗死36例临床观察[J].临床医药实践,2014,19(12):961-962.

相似文献/References:

[1]梁道博,姚卜飞,夏双燕.氯吡格雷联合阿司匹林治疗急性冠脉综合征疗效与 安全性的Meta分析[J].医学信息,2019,32(11):76.[doi:10.3969/j.issn.1006-1959.2019.11.021]
　LIANG Dao-bo,YAO Bu-fei,XIA Shuang-yan.Meta-analysis of the Efficacy and Safety of Clopidogrel Combined with Aspirin in the Treatment of Acute Coronary Syndrome[J].Medical Information,2019,32(09):76.[doi:10.3969/j.issn.1006-1959.2019.11.021]
[2]王 焕.替格瑞洛在氯吡格雷抵抗AMI患者PCI术后抗血小板治疗中的应用[J].医学信息,2019,32(24):153.[doi:10.3969/j.issn.1006-1959.2019.24.055]
　WANG Huan.Application of Ticagrelor in the Antiplatelet Therapy of Clopidogrel in Patients with AMI after PCI[J].Medical Information,2019,32(09):153.[doi:10.3969/j.issn.1006-1959.2019.24.055]
[3]刘廷胜.氯吡格雷联合阿司匹林治疗急性心肌梗死的研究[J].医学信息,2020,33(06):59.[doi:10.3969/j.issn.1006-1959.2020.06.018]
　LIU Ting-sheng.A Study of Clopidogrel Combined with Aspirin in the Treatment of Acute Myocardial Infarction[J].Medical Information,2020,33(09):59.[doi:10.3969/j.issn.1006-1959.2020.06.018]
[4]刘 楠.阿司匹林联合氯吡格雷双抗血小板治疗脑梗死的疗效观察及对血清hs-CRP及D-D水平的影响[J].医学信息,2022,35(19):82.[doi:10.3969/j.issn.1006-1959.2022.19.022]
　LIU Nan.The Effect of Aspirin Combined with Clopidogrel Dual Antiplatelet Therapy on Cerebral Infarction and its Effect on Serum hs-CRP and D-D Levels[J].Medical Information,2022,35(09):82.[doi:10.3969/j.issn.1006-1959.2022.19.022]
[5]赵东慧.阿替普酶静脉溶栓联合氯吡格雷对急性脑梗死患者脑血流动力学及CRP、Hcy、HDL-C水平的影响[J].医学信息,2022,35(20):74.[doi:10.3969/j.issn.1006-1959.2022.20.018]
　ZHAO Dong-hui.Effect of Alteplase Intravenous Thrombolysis Combined with Clopidogrel on Cerebral Hemodynamics and Levels of CRP, Hcy and HDL-C in Patients with Acute Cerebral Infarction[J].Medical Information,2022,35(09):74.[doi:10.3969/j.issn.1006-1959.2022.20.018]
[6]刘梓良,曹德斌.氯吡格雷联合阿托伐他汀钙治疗缺血性脑卒中患者的疗效及对神经功能的影响[J].医学信息,2021,34(17):111.[doi:10.3969/j.issn.1006-1959.2021.17.028]
　LIU Zi-liang,CAO De-bin.Efficacy of Clopidogrel Combined with Atorvastatin Calcium in the Treatment of Patients with Ischemic Stroke and its Effect on Neurological Function[J].Medical Information,2021,34(09):111.[doi:10.3969/j.issn.1006-1959.2021.17.028]
[7]张莹莹,郭绪昆,刘 寅.氯吡格雷药代动力学特点及其在心血管疾病中的临床应用[J].医学信息,2021,34(20):45.[doi:10.3969/j.issn.1006-1959.2021.20.011]
　ZHANG Ying-ying,GUO Xu-kun,LIU Yin.Pharmacokinetic Characteristics of Clopidogrel and the Clinical Application in Cardiovascular Diseases[J].Medical Information,2021,34(09):45.[doi:10.3969/j.issn.1006-1959.2021.20.011]
[8]刘亦杰.跟踪护理对氯吡格雷治疗急性PCI术后患者冠脉再狭窄的预防效果研究[J].医学信息,2023,36(24):155.[doi:10.3969/j.issn.1006-1959.2023.24.036]
　LIU Yi-jie.Study on the Preventive Effect of Tracking Nursing on Coronary Restenosis in Patients with Acute PCI After Clopidogrel Treatment[J].Medical Information,2023,36(09):155.[doi:10.3969/j.issn.1006-1959.2023.24.036]
[9]曹美娜,刘小平,郑艳安,等.CYP2C19基因型对急性心脑血管梗塞患者预后的影响[J].医学信息,2024,37(03):109.[doi:10.3969/j.issn.1006-1959.2024.03.021]
　CAO Mei-na,LIU Xiao-ping,ZHENG Yan-an,et al.Effect of CYP2C19 Genotype on the Prognosis of Patients with Acute Cardiovascular and Cerebrovascular Infarction[J].Medical Information,2024,37(09):109.[doi:10.3969/j.issn.1006-1959.2024.03.021]
[10]高宏洪.阿司匹林联合氯吡格雷治疗对脑梗塞患者凝血功能及血液流变学的影响[J].医学信息,2024,37(10):141.[doi:10.3969/j.issn.1006-1959.2024.10.030]
　GAO Hong-hong.Effect of Aspirin Combined with Clopidogrel on Coagulation Function and Hemorheology in Patients with Cerebral Infarction[J].Medical Information,2024,37(09):141.[doi:10.3969/j.issn.1006-1959.2024.10.030]

更新日期/Last Update: 2020-05-01